Potential of syringol and guaiacol in mitigating hyperglycemia associated dicarbonyl stress in rats subjected to high-fat high-fructose diet
Journal of Pharmacy and Pharmacology · 2025
DOI: 10.1093/jpp/rgaf071 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2025. Verfasst von Iqra Yousaf und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Institute of Pharmacy, Faculty of Pharmaceutical and Allied Health Sciences, Lahore College for Women University, Jail ro…. Hauptthemen laut MEDLINE: Guaiacol, Hyperglycemia, Oxidative Stress, Fructose. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben.
Abstract (Originalsprache)
Objective
The current study assessed the pharmacological potential of syringol and guaiacol, both separately and in combination, in hyperglycemia linked to dicarbonyl stress (DS).
Methods
The control group (n = 5) received a standard diet with Tween 20 and disease group received high-fat high-fructose diet. The remaining four groups received metformin, syringol (100 μg/kg), guaiacol (100 μg/kg), or a combination of both (50 + 50 μg/kg) starting on the 29th day and lasting 30 days. After study completion, glucose intolerance, oxidative stress markers, glycated products, liver, renal, lipid markers along with liver and pancreatic histology were assessed. NF-κB, TNF-α, IL-6, IL-1β, and nuclear factor erythroid 2-related factor 2 (Nrf2) expression levels were estimated using reverse transcriptase-quantitative polymerase chain reaction (RT-qPCR). Key findings Combination therapy markedly decreased weight (31.30%), fasting blood glucose (74.92%), glucose intolerance (65.42%), and improved biochemical markers of lipid, hepatic, and renal function. The combination therapy significantly reduced (P < .05) malondialdehyde, nitric oxide, expression of NF-κB, TNF-α, IL-6, and IL-1β while increasing superoxide dismutase, catalase and reduced glutathione levels. Combination therapy significantly (P < .05) reduced HbA1c levels and increased Glo1, Glo2, and Nrf-2 levels. Histopathological variations showed reduced cellular damage in the treatment groups.
Conclusion
Combination of syringol and guaiacol exhibits significant pharmacological efficacy for managing DS associated with hyperglycemia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Institute of Pharmacy, Faculty of Pharmaceutical and Allied Health Sciences, Lahore College for Women University, Jail road, Lahore, Punjab 54000, Pakistan.
- Department of Pharmaceutics, Institute of Pharmacy, Faculty of Pharmaceutical and Allied Health Sciences, Lahore College for Women University, Jail road, Lahore, Punjab 54000, Pakistan.
- Department of Pharmacognosy, Faculty of Pharmacy, Gomal University, Dera Ismail Khan, Khyber Pakhtunkhwa 29050, Pakistan.
- School of Biochemistry and Biotechnology, Quaid-e-Azam Campus, University of the Punjab, Lahore 54590, Pakistan.
ORCID-Profile: Iqra Yousaf, Sairah Hafeez Kamran, Iram Gull
Zitieren
APA
Yousaf, I., Kamran, S. H., Naseem, A., Afzal, H., Naz, R., Amin, A., & Gull, I. (2025). Potential of syringol and guaiacol in mitigating hyperglycemia associated dicarbonyl stress in rats subjected to high-fat high-fructose diet. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgaf071
Vancouver
Yousaf I, Kamran SH, Naseem A, Afzal H, Naz R, Amin A, et al. Potential of syringol and guaiacol in mitigating hyperglycemia associated dicarbonyl stress in rats subjected to high-fat high-fructose diet. Journal of Pharmacy and Pharmacology. 2025. doi:10.1093/jpp/rgaf071
BibTeX
@article{Yousaf2025,
author = {Yousaf, Iqra and Kamran, Sairah Hafeez and Naseem, Afshan and Afzal, Hafsa and Naz, Rida and Amin, Adnan and Gull, Iram},
title = {Potential of syringol and guaiacol in mitigating hyperglycemia associated dicarbonyl stress in rats subjected to high-fat high-fructose diet},
journal = {Journal of Pharmacy and Pharmacology},
year = {2025},
doi = {10.1093/jpp/rgaf071}
}
EUVIMED